Thumb Arthritis Market Size Analysis by Growth Application, Segmentation and Forecast to 2023

10/set/2019 13:12:26 Market Research Future Contatta l'autore

Market Highlights

In thumb arthritis, the cushion-like cartilage inside the CMC joint breaks down, causing the bones to rub against each other. Increasing prevalence of thumb arthritis, growing geriatric and obese population, and rising healthcare expenditure during the forecast period. The study was published in the HAND (American Association for Hand Surgery) journal in 2016, according to the prevalence of the thumb However, the high cost of surgical therapeutics along with related complications is estimated to restrain the market growth during the forecast period.

The Global Thumb Arthritis Market is expected to grow at an approximate CAGR of 8.1% during the forecast period.


The global thumb arthritis market is segmented on the basis of type, diagnosis, treatment, and end user. On the basis of the type, the market is segmented into osteoarthritis thumb arthritis, rheumatoid thumb arthritis, and others. On the basis of the diagnosis, the market is segmented into physical examinations, imaging, fine needle aspiration (FNA), and others. The imaging segment is sub-segmented into X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and others.

On the basis of the treatment, the market is segmented into thumb exercise, medication, surgery, and others. The medication segment is sub-segmented into OCT medications, prescription medications, and others. The surgery segment is sub-segmented into trapeziectomy, osteotomy, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, research organizations, retail pharmacies, and others.

Request For Sample Report:

Regional Analysis

The Americas dominate the global thumb arthritis market. A well-developed healthcare sector, growing geriatric population, and increasing healthcare expenditure are the major drivers for the growth of the global thumb arthritis market.

Europe holds the second largest thumb arthritis market owing to the availability of the funds for research, increasing surgery adoption rates, and growing patient population. According to the Office for National Statistics the geriatric population within the region is expected to grow and reach 20.5% of the total U.K population by 2026 from 18.0% in 2016.

Asia Pacific is the fastest growing region. Growing geriatric and obese population followed by developing healthcare sectors are boosting the market growth. Within the region, Australia holds a significant ratio of the obese population. However, the presence of developing economies like India and China are marked by expanding healthcare sector. This is estimated to provide favorable backgrounds for market growth.

The Middle East and Africa region accounts for the least market share. This is mainly due to the lack of income and the lack of medical services. On the other, the Middle East holds the largest market share within the region.

Browse Full Report @ 

Key Players

The key players in the global thumb arthritis market are inclusive of BioPro (US), McKie Splints (US), AbbVie Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Pfizer Inc . (US), Carestream Health. (US), General Electric Company (UK), and others.

blog comments powered by Disqus รจ un servizio offerto da Factotum Srl